haloperidol has been researched along with Atherosclerosis in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we evaluated the potential of the typical antipsychotic drug haloperidol to modulate the cholesterol efflux function of macrophages in vitro and their susceptibility to atherosclerosis in vivo." | 3.81 | Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. ( Hoekstra, M; Nahon, JE; Reuwer, AQ; van der Sluis, RJ; Van Eck, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Sluis, RJ | 1 |
| Nahon, JE | 1 |
| Reuwer, AQ | 1 |
| Van Eck, M | 1 |
| Hoekstra, M | 1 |
1 other study available for haloperidol and Atherosclerosis
| Article | Year |
|---|---|
Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
Topics: Animals; Antipsychotic Agents; Aorta; Aortic Diseases; Apolipoprotein A-I; Atherosclerosis; ATP Bind | 2015 |